In the study by Li et al. [41], the authors demonstrated that the CD44-mediated TGF-β1 and EGF signaling, and the co-localization of CD44/EGFR influenced the activation of EGF signaling induced by TGF-β1 in lung and breast cancer cells. This evidence concerns the gene EGFR and breast carcinoma.